Beta-blockers after acute coronary syndrome: insights across the ejection fraction spectrum.
Aims To evaluate the association between beta-blocker (BB) prescription and long-term all-cause mortality after acute coronary syndrome (ACS), and to assess whether this varies across the left ventricular ejection fraction (LVEF) spectrum. Methods and results We analysed ACS patients from the retrospective multicentr...